Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

73 recalls, newest first

Class II · Moderate risk

fentaNYL 400 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1440-76 D-0554-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1225-37 D-0552-2020
Class II · Moderate risk

fentaNYL 1500 mcg/30 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1099-49 D-0551-2020
Class II · Moderate risk

fentaNYL 200 mcg/100 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1104-36 D-0550-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1269-37 D-0549-2020
Class II · Moderate risk

fentaNYL 200 mcg/100 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1259-75 D-0548-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1105-37 D-0547-2020
Class II · Moderate risk

fentaNYL 500 mcg/250 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1160-37 D-0546-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-9 D-0299-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-8 D-0298-2020

Recalls by year